SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0931 041X "

Sökning: L773:0931 041X

  • Resultat 21-30 av 177
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
21.
  • Chavers, Blanche M., et al. (författare)
  • Hyperlipidemia in pediatric kidney transplant recipients treated with cyclosporine
  • 2003
  • Ingår i: Pediatric nephrology (Berlin, West). - : Elsevier. - 0931-041X .- 1432-198X. ; 18:6, s. 565-569
  • Tidskriftsartikel (refereegranskat)abstract
    • Hyperlipidemia is a risk factor for cardiovascular disease in adult kidney transplant (Tx) recipients. We sought to determine the prevalence of, and the risk factors associated with, hyperlipidemia in pediatric kidney Tx recipients on cyclosporine (CsA). We identified 59 patients (mean age 8.2+/-5.7 years) transplanted between 1 January 1991 and 31 December 1993. Pre Tx, 34% had elevated total cholesterol [TC >200 mg/dl (5.17 mmol/l)]; 54% had elevated triglycerides [TG >200 mg/dl (2.26 mmol/L)]. Mean TG was higher pre Tx in dialysis (versus nondialysis) patients: 306 mg/dl (3.46 mmol/l) versus 228 mg/dl (2.58 mmol/l) ( P=0.04). Mean TC was higher in peritoneal dialysis than hemodialysis patients: 222 mg/dl (5.74 mmol/l) versus 169 mg/dl (4.37 mmol/l) ( P=0.03). Pre Tx and 3-year values correlated (TC, r=0.49, P=0.0008; TG, r=0.41, P=0.001); 3- and 5-year TC values correlated ( r=0.57, P=0.003). At 5 years post Tx, 41% of the recipients had elevated TC; 14% had elevated TG. Recipients with elevated TC had higher mean CsA concentrations at 1 year post Tx ( P=0.03). Recipients with elevated TG tended to receive more prednisone ( P=0.06). At 5 years post Tx, recipients had a high prevalence of hyperlipidemia. The identification and treatment of hyperlipidemia should be included in pediatric kidney Tx protocols. 
  •  
22.
  •  
23.
  •  
24.
  •  
25.
  •  
26.
  •  
27.
  •  
28.
  •  
29.
  • Coppo, Rosanna, et al. (författare)
  • Risk factors for progression in children and young adults with IgA nephropathy : an analysis of 261 cases from the VALIGA European cohort
  • 2017
  • Ingår i: Pediatric nephrology (Berlin, West). - : Springer Science and Business Media LLC. - 0931-041X .- 1432-198X. ; 32:1, s. 139-150
  • Tidskriftsartikel (refereegranskat)abstract
    • There is a need for early identification of children with immunoglobulin A nephropathy (IgAN) at risk of progression of kidney disease. Data on 261 young patients [age < 23 years; mean follow-up of 4.9 (range 2.5-8.1) years] enrolled in VALIGA, a study designed to validate the Oxford Classification of IgAN, were assessed. Renal biopsies were scored for the presence of mesangial hypercellularity (M1), endocapillary hypercellularity (E1), segmental glomerulosclerosis (S1), tubular atrophy/interstitial fibrosis (T1-2) (MEST score) and crescents (C1). Progression was assessed as end stage renal disease and/or a 50 % loss of estimated glomerular filtration rate (eGFR) (combined endpoint) as well as the rate of renal function decline (slope of eGFR). Cox regression and tree classification binary models were used and compared. In this cohort of 261 subjects aged < 23 years, Cox analysis validated the MEST M, S and T scores for predicting survival to the combined endpoint but failed to prove that these scores had predictive value in the sub-group of 174 children aged < 18 years. The regression tree classification indicated that patients with M1 were at risk of developing higher time-averaged proteinuria (p < 0.0001) and the combined endpoint (p < 0.001). An initial proteinuria of ae0.4 g/day/1.73 m(2) and an eGFR of < 90 ml/min/1.73 m(2) were determined to be risk factors in subjects with M0. Children aged < 16 years with M0 and well-preserved eGFR (> 90 ml/min/1.73 m(2)) at presentation had a significantly high probability of proteinuria remission during follow-up and a higher remission rate following treatment with corticosteroid and/or immunosuppressive therapy. This new statistical approach has identified clinical and histological risk factors associated with outcome in children and young adults with IgAN.
  •  
30.
  • Dasgupta, Indranil, et al. (författare)
  • Validating the use of bioimpedance spectroscopy for assessment of fluid status in children.
  • 2018
  • Ingår i: Pediatric nephrology. - : Springer Science and Business Media LLC. - 1432-198X .- 0931-041X. ; 33:9, s. 1601-1607
  • Tidskriftsartikel (refereegranskat)abstract
    • Bioimpedance spectroscopy (BIS) with a whole-body model to distinguish excess fluid from major body tissue hydration can provide objective assessment of fluid status. BIS is integrated into the Body Composition Monitor (BCM) and is validated in adults, but not children. This study aimed to (1) assess agreement between BCM-measured total body water (TBW) and a gold standard technique in healthy children, (2) compare TBW_BCM with TBW from Urea Kinetic Modelling (UKM) in haemodialysis children and (3) investigate systematic deviation from zero in measured excess fluid in healthy children across paediatric age range.TBW_BCM and excess fluid was determined from standard wrist-to-ankle BCM measurement. TBW_D2O was determined from deuterium concentration decline in serial urine samples over 5days in healthy children. UKM was used to measure body water in children receiving haemodialysis. Agreement between methods was analysed using paired t test and Bland-Altman method comparison.In 61 healthy children (6-14years, 32 male), mean TBW_BCM and TBW_D2O were 21.1±5.6and 20.5±5.8L respectively. There was good agreement between TBW_BCM and TBW_D2O (R2=0.97). In six haemodialysis children (4-13years, 4 male), 45 concomitant measurements over 8months showed good TBW_BCM and TBW_UKM agreement (mean difference -0.4L, 2SD=±3.0L). In 634 healthy children (2-17years, 300 male), BCM-measured overhydration was -0.1±0.7L (10-90th percentile -0.8 to+0.6L). There was no correlation between age and OH (p=0.28).These results suggest BCM can be used in children as young as 2years to measure normally hydrated weight and assess fluid status.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 21-30 av 177
Typ av publikation
tidskriftsartikel (135)
konferensbidrag (37)
forskningsöversikt (5)
Typ av innehåll
refereegranskat (133)
övrigt vetenskapligt/konstnärligt (44)
Författare/redaktör
Herthelius, M (19)
Karpman, Diana (15)
Berg, U. (14)
Chromek, M (13)
Hansson, Sverker, 19 ... (12)
Berg, UB (11)
visa fler...
Celsi, G (10)
Jodal, Ulf, 1938 (9)
Mehls, O (9)
Krmar, RT (9)
Barany, P (8)
Bekassy, Zivile (8)
Brauner, A (7)
Nevéus, Tryggve (7)
Schaefer, F (7)
Vanpee, M (6)
Sixt, Rune (5)
Aperia, A (5)
Axelsson, J (5)
Luthje, P (5)
Lindblad, YT (5)
Vavilis, G (5)
Jacobson, SH (4)
Sjöblad, Sture (4)
Torffvit, Ole (4)
Björk, Jonas (4)
Tryggvason, K (4)
Nyman, Ulf (4)
Besbas, Nesrin (4)
Holmquist, Peter (4)
Wingen, AM (4)
Hansson, Magnus (3)
Soderberg, M (3)
Chen, M (3)
Agerberth, B (3)
Grubb, Anders (3)
Barregård, Lars, 194 ... (3)
Rosenblad, Therese (3)
Schmitt, CP (3)
Testa, S (3)
Ariceta, Gema (3)
Johnson, Sally (3)
Landau, Daniel (3)
Licht, Christoph (3)
Loirat, Chantal (3)
Pecoraro, Carmine (3)
Herthelius, Maria (3)
Asling-Monemi, K (3)
Wuhl, E (3)
Back, R (3)
visa färre...
Lärosäte
Karolinska Institutet (114)
Lunds universitet (34)
Göteborgs universitet (24)
Uppsala universitet (15)
Kungliga Tekniska Högskolan (3)
Umeå universitet (2)
visa fler...
Högskolan i Gävle (1)
Örebro universitet (1)
Linköpings universitet (1)
visa färre...
Språk
Engelska (177)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (66)
Naturvetenskap (3)
Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy